Rosenberg Noah L. 4
4 · Travere Therapeutics, Inc. · Filed May 13, 2021
Insider Transaction Report
Form 4
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-05-11$19.14/sh−375$7,178→ 45,969 total - Sale
Common Stock
2021-05-12$19.46/sh−375$7,298→ 45,594 total
Footnotes (1)
- [F1]The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.